Thomas Baumert
8Patents
2h-index
9Co-inventors
44Inventor score
Filing activity: Apr 21, 1999 → Oct 27, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6387662B1 | Synthesis and purification of hepatitis C virus-like particles | Emerging Cross-Sectional Technologies | 12 | Expired |
| US8518408B2 | Monoclonal anti-claudin 1 antibodies for the inhibition of hepatitis C virus infection | Chemistry; Metallurgy | 5 | Active |
| US10988737B2 | Clinical gene signature-based human cell culture model and uses thereof | Physics | 1 | Active |
| US8759010B2 | Host cell kinases as targets for antiviral therapies against HCV infection | Physics | 0 | Active |
| US11365251B2 | Humanized anti-claudin-1 antibodies and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US10851160B2 | Humanized anti-claudin-1 antibodies and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US10815298B2 | Anti-claudin 1 monoclonal antibodies for the prevention and treatment of hepatocellular carcinoma | Chemistry; Metallurgy | 0 | Active |
| US10927170B2 | Anti-claudin 1 monoclonal antibodies for the prevention and treatment of hepatocellular carcinoma | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.